Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526643
Status:
TERMINATED
Last Update Posted:
2017-03-28
First Post:
2007-09-06
Brief Title:
CAPPA-2 Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
Sponsor:
National Cancer Institute Naples
Organization:
National Cancer Institute Naples
Organization Data
Organization:
National Cancer Institute Naples
Class:
OTHER
Study ID:
CAPPA-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute Naples
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Northwest Oncology Cooperative GroupGONO | UNKNOWN |
| Clinical Trials Promoting Group APRICCTPG | UNKNOWN |
| Gruppo Oncologico del Lazio GOL | UNKNOWN |
| Gruppo Italiano per lo studio dei Carcinomi dellApparato Digerente | OTHER |
| Gruppo Oncologico Italiano di Ricerca ClinicaGOIRC | UNKNOWN |
| Gruppo Oncologico Italia Meridionale | OTHER |